nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—VEGFA—systemic lupus erythematosus	0.303	0.508	CbGaD
Minocycline—MMP9—systemic lupus erythematosus	0.293	0.492	CbGaD
Minocycline—SLC22A11—Methotrexate—systemic lupus erythematosus	0.0291	0.27	CbGbCtD
Minocycline—SLC22A7—Methotrexate—systemic lupus erythematosus	0.0277	0.257	CbGbCtD
Minocycline—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.0222	0.207	CbGbCtD
Minocycline—SLC22A8—Methotrexate—systemic lupus erythematosus	0.0169	0.157	CbGbCtD
Minocycline—CASP3—alveolus of lung—systemic lupus erythematosus	0.0147	0.124	CbGeAlD
Minocycline—SLC22A6—Methotrexate—systemic lupus erythematosus	0.0118	0.109	CbGbCtD
Minocycline—IL1B—synovial fluid—systemic lupus erythematosus	0.00964	0.0813	CbGeAlD
Minocycline—MMP9—synovial fluid—systemic lupus erythematosus	0.00803	0.0677	CbGeAlD
Minocycline—MMP9—tunica intima—systemic lupus erythematosus	0.00636	0.0536	CbGeAlD
Minocycline—SLC22A8—choroid plexus—systemic lupus erythematosus	0.00625	0.0527	CbGeAlD
Minocycline—CYCS—blood plasma—systemic lupus erythematosus	0.00286	0.0241	CbGeAlD
Minocycline—CASP3—endothelium—systemic lupus erythematosus	0.00276	0.0233	CbGeAlD
Minocycline—CASP3—blood plasma—systemic lupus erythematosus	0.00245	0.0207	CbGeAlD
Minocycline—IL1B—endothelium—systemic lupus erythematosus	0.00221	0.0186	CbGeAlD
Minocycline—IL1B—blood plasma—systemic lupus erythematosus	0.00196	0.0165	CbGeAlD
Minocycline—MMP9—endothelium—systemic lupus erythematosus	0.00184	0.0155	CbGeAlD
Minocycline—SLC22A8—urine—systemic lupus erythematosus	0.00167	0.0141	CbGeAlD
Minocycline—MMP9—blood plasma—systemic lupus erythematosus	0.00163	0.0138	CbGeAlD
Minocycline—CASP1—connective tissue—systemic lupus erythematosus	0.00158	0.0133	CbGeAlD
Minocycline—CYCS—connective tissue—systemic lupus erythematosus	0.00152	0.0129	CbGeAlD
Minocycline—CASP1—skin of body—systemic lupus erythematosus	0.00143	0.0121	CbGeAlD
Minocycline—CYCS—skin of body—systemic lupus erythematosus	0.00138	0.0116	CbGeAlD
Minocycline—CASP1—kidney—systemic lupus erythematosus	0.00135	0.0114	CbGeAlD
Minocycline—CASP1—cortex of kidney—systemic lupus erythematosus	0.00131	0.0111	CbGeAlD
Minocycline—CASP3—connective tissue—systemic lupus erythematosus	0.00131	0.011	CbGeAlD
Minocycline—CYCS—kidney—systemic lupus erythematosus	0.0013	0.0109	CbGeAlD
Minocycline—CASP3—nephron tubule—systemic lupus erythematosus	0.00126	0.0107	CbGeAlD
Minocycline—CASP3—skin of body—systemic lupus erythematosus	0.00118	0.00994	CbGeAlD
Minocycline—CASP1—lymphoid tissue—systemic lupus erythematosus	0.00116	0.00976	CbGeAlD
Minocycline—CYCS—lymphoid tissue—systemic lupus erythematosus	0.00111	0.0094	CbGeAlD
Minocycline—CASP3—kidney—systemic lupus erythematosus	0.00111	0.00937	CbGeAlD
Minocycline—CASP1—tendon—systemic lupus erythematosus	0.00109	0.00918	CbGeAlD
Minocycline—CASP1—bone marrow—systemic lupus erythematosus	0.00105	0.00889	CbGeAlD
Minocycline—IL1B—connective tissue—systemic lupus erythematosus	0.00104	0.00879	CbGeAlD
Minocycline—CYCS—bone marrow—systemic lupus erythematosus	0.00101	0.00856	CbGeAlD
Minocycline—VEGFA—nephron tubule—systemic lupus erythematosus	0.000994	0.00838	CbGeAlD
Minocycline—CASP1—lung—systemic lupus erythematosus	0.000955	0.00805	CbGeAlD
Minocycline—CASP3—lymphoid tissue—systemic lupus erythematosus	0.000955	0.00805	CbGeAlD
Minocycline—IL1B—skin of body—systemic lupus erythematosus	0.000942	0.00794	CbGeAlD
Minocycline—CYCS—lung—systemic lupus erythematosus	0.00092	0.00775	CbGeAlD
Minocycline—CASP3—tendon—systemic lupus erythematosus	0.000898	0.00757	CbGeAlD
Minocycline—IL1B—kidney—systemic lupus erythematosus	0.000888	0.00749	CbGeAlD
Minocycline—CASP1—nervous system—systemic lupus erythematosus	0.000885	0.00746	CbGeAlD
Minocycline—CASP3—bone marrow—systemic lupus erythematosus	0.000869	0.00733	CbGeAlD
Minocycline—MMP9—connective tissue—systemic lupus erythematosus	0.000869	0.00733	CbGeAlD
Minocycline—CASP1—central nervous system—systemic lupus erythematosus	0.000852	0.00718	CbGeAlD
Minocycline—CYCS—nervous system—systemic lupus erythematosus	0.000852	0.00718	CbGeAlD
Minocycline—VEGFA—cortex of kidney—systemic lupus erythematosus	0.000851	0.00717	CbGeAlD
Minocycline—CYCS—central nervous system—systemic lupus erythematosus	0.00082	0.00691	CbGeAlD
Minocycline—SLC22A11—nephron tubule—systemic lupus erythematosus	0.000798	0.00673	CbGeAlD
Minocycline—CASP3—lung—systemic lupus erythematosus	0.000788	0.00664	CbGeAlD
Minocycline—MMP9—skin of body—systemic lupus erythematosus	0.000785	0.00662	CbGeAlD
Minocycline—IL1B—lymphoid tissue—systemic lupus erythematosus	0.000763	0.00643	CbGeAlD
Minocycline—SLC22A6—nephron tubule—systemic lupus erythematosus	0.000752	0.00634	CbGeAlD
Minocycline—MMP9—kidney—systemic lupus erythematosus	0.00074	0.00624	CbGeAlD
Minocycline—CASP3—nervous system—systemic lupus erythematosus	0.000729	0.00615	CbGeAlD
Minocycline—IL1B—tendon—systemic lupus erythematosus	0.000717	0.00604	CbGeAlD
Minocycline—VEGFA—tendon—systemic lupus erythematosus	0.000705	0.00594	CbGeAlD
Minocycline—CASP3—central nervous system—systemic lupus erythematosus	0.000702	0.00592	CbGeAlD
Minocycline—SLC22A11—kidney—systemic lupus erythematosus	0.000702	0.00591	CbGeAlD
Minocycline—IL1B—bone marrow—systemic lupus erythematosus	0.000695	0.00585	CbGeAlD
Minocycline—ALOX5—connective tissue—systemic lupus erythematosus	0.000687	0.00579	CbGeAlD
Minocycline—SLC22A7—kidney—systemic lupus erythematosus	0.000685	0.00577	CbGeAlD
Minocycline—SLC22A11—cortex of kidney—systemic lupus erythematosus	0.000683	0.00576	CbGeAlD
Minocycline—VEGFA—bone marrow—systemic lupus erythematosus	0.000683	0.00576	CbGeAlD
Minocycline—SLC22A7—cortex of kidney—systemic lupus erythematosus	0.000667	0.00562	CbGeAlD
Minocycline—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.000644	0.00543	CbGeAlD
Minocycline—MMP9—lymphoid tissue—systemic lupus erythematosus	0.000636	0.00536	CbGeAlD
Minocycline—IL1B—lung—systemic lupus erythematosus	0.000629	0.0053	CbGeAlD
Minocycline—VEGFA—lung—systemic lupus erythematosus	0.000619	0.00522	CbGeAlD
Minocycline—MMP9—tendon—systemic lupus erythematosus	0.000598	0.00504	CbGeAlD
Minocycline—IL1B—nervous system—systemic lupus erythematosus	0.000583	0.00491	CbGeAlD
Minocycline—MMP9—bone marrow—systemic lupus erythematosus	0.000579	0.00488	CbGeAlD
Minocycline—IL1B—central nervous system—systemic lupus erythematosus	0.000561	0.00473	CbGeAlD
Minocycline—MMP9—lung—systemic lupus erythematosus	0.000524	0.00442	CbGeAlD
Minocycline—ALOX5—lymphoid tissue—systemic lupus erythematosus	0.000503	0.00424	CbGeAlD
Minocycline—MMP9—nervous system—systemic lupus erythematosus	0.000486	0.00409	CbGeAlD
Minocycline—MMP9—central nervous system—systemic lupus erythematosus	0.000468	0.00394	CbGeAlD
Minocycline—CYCS—Sulfisoxazole—Dapsone—systemic lupus erythematosus	0.000461	0.0928	CbGdCrCtD
Minocycline—ALOX5—bone marrow—systemic lupus erythematosus	0.000458	0.00386	CbGeAlD
Minocycline—SLC22A8—nephron tubule—systemic lupus erythematosus	0.00045	0.0038	CbGeAlD
Minocycline—ALOX5—lung—systemic lupus erythematosus	0.000415	0.00349	CbGeAlD
Minocycline—Methacycline—ALB—systemic lupus erythematosus	0.000407	0.696	CrCbGaD
Minocycline—SLC22A8—kidney—systemic lupus erythematosus	0.000396	0.00334	CbGeAlD
Minocycline—SLC22A8—cortex of kidney—systemic lupus erythematosus	0.000385	0.00325	CbGeAlD
Minocycline—ALOX5—nervous system—systemic lupus erythematosus	0.000384	0.00324	CbGeAlD
Minocycline—ALOX5—central nervous system—systemic lupus erythematosus	0.00037	0.00312	CbGeAlD
Minocycline—SLC22A8—nervous system—systemic lupus erythematosus	0.00026	0.00219	CbGeAlD
Minocycline—IL1B—Methylprednisolone—Hydrocortisone—systemic lupus erythematosus	0.000258	0.0521	CbGdCrCtD
Minocycline—SLC22A8—central nervous system—systemic lupus erythematosus	0.00025	0.00211	CbGeAlD
Minocycline—CYCS—Sulfathiazole—Dapsone—systemic lupus erythematosus	0.000242	0.0488	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Betamethasone—systemic lupus erythematosus	0.00024	0.0484	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Dexamethasone—systemic lupus erythematosus	0.00024	0.0484	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Triamcinolone—systemic lupus erythematosus	0.000234	0.0473	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Prednisone—systemic lupus erythematosus	0.000222	0.0448	CbGdCrCtD
Minocycline—IL1B—Methylprednisolone—Prednisolone—systemic lupus erythematosus	0.000217	0.0438	CbGdCrCtD
Minocycline—Tetracycline—ALB—systemic lupus erythematosus	0.000178	0.305	CrCbGaD
Minocycline—IL1B—Fluorometholone—Hydrocortisone—systemic lupus erythematosus	0.00016	0.0323	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Methylprednisolone—systemic lupus erythematosus	0.000151	0.0305	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Betamethasone—systemic lupus erythematosus	0.000149	0.03	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Dexamethasone—systemic lupus erythematosus	0.000149	0.03	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Triamcinolone—systemic lupus erythematosus	0.000145	0.0293	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Prednisone—systemic lupus erythematosus	0.000138	0.0278	CbGdCrCtD
Minocycline—IL1B—Fluorometholone—Prednisolone—systemic lupus erythematosus	0.000135	0.0271	CbGdCrCtD
Minocycline—IL1B—Budesonide—Hydrocortisone—systemic lupus erythematosus	0.000107	0.0215	CbGdCrCtD
Minocycline—IL1B—Budesonide—Methylprednisolone—systemic lupus erythematosus	0.000101	0.0203	CbGdCrCtD
Minocycline—IL1B—Budesonide—Dexamethasone—systemic lupus erythematosus	9.93e-05	0.02	CbGdCrCtD
Minocycline—IL1B—Budesonide—Betamethasone—systemic lupus erythematosus	9.93e-05	0.02	CbGdCrCtD
Minocycline—IL1B—Budesonide—Triamcinolone—systemic lupus erythematosus	9.7e-05	0.0196	CbGdCrCtD
Minocycline—IL1B—Budesonide—Prednisone—systemic lupus erythematosus	9.21e-05	0.0186	CbGdCrCtD
Minocycline—IL1B—Budesonide—Prednisolone—systemic lupus erythematosus	8.99e-05	0.0181	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	6.54e-05	0.0132	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Hydrocortisone—systemic lupus erythematosus	6.54e-05	0.0132	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Methylprednisolone—systemic lupus erythematosus	6.17e-05	0.0124	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	6.17e-05	0.0124	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Betamethasone—systemic lupus erythematosus	6.07e-05	0.0122	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Dexamethasone—systemic lupus erythematosus	6.07e-05	0.0122	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Triamcinolone—systemic lupus erythematosus	5.93e-05	0.012	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Triamcinolone—systemic lupus erythematosus	5.93e-05	0.012	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Prednisone—systemic lupus erythematosus	5.63e-05	0.0114	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Prednisone—systemic lupus erythematosus	5.63e-05	0.0114	CbGdCrCtD
Minocycline—IL1B—Dexamethasone—Prednisolone—systemic lupus erythematosus	5.5e-05	0.0111	CbGdCrCtD
Minocycline—IL1B—Betamethasone—Prednisolone—systemic lupus erythematosus	5.5e-05	0.0111	CbGdCrCtD
Minocycline—CASP3—Signaling by NGF—CDKN1B—systemic lupus erythematosus	3.53e-05	0.000205	CbGpPWpGaD
Minocycline—IL1B—Immune System—IRF5—systemic lupus erythematosus	3.53e-05	0.000205	CbGpPWpGaD
Minocycline—VEGFA—Betamethasone—Hydrocortisone—systemic lupus erythematosus	3.49e-05	0.00704	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	3.49e-05	0.00704	CbGdCrCtD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—systemic lupus erythematosus	3.49e-05	0.000202	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP9—systemic lupus erythematosus	3.49e-05	0.000202	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	3.48e-05	0.000202	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—JAK1—systemic lupus erythematosus	3.44e-05	0.0002	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—TYK2—systemic lupus erythematosus	3.43e-05	0.000199	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ADIPOQ—systemic lupus erythematosus	3.41e-05	0.000198	CbGpPWpGaD
Minocycline—IL1B—Immune System—IRF8—systemic lupus erythematosus	3.38e-05	0.000196	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFIH1—systemic lupus erythematosus	3.38e-05	0.000196	CbGpPWpGaD
Minocycline—IL1B—Immune System—ITGAM—systemic lupus erythematosus	3.38e-05	0.000196	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD247—systemic lupus erythematosus	3.38e-05	0.000196	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DQB1—systemic lupus erythematosus	3.37e-05	0.000195	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—RXRA—systemic lupus erythematosus	3.37e-05	0.000195	CbGpPWpGaD
Minocycline—CYCS—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	3.33e-05	0.00672	CbGdCrCtD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.31e-05	0.000192	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	3.3e-05	0.000191	CbGpPWpGaD
Minocycline—VEGFA—Betamethasone—Methylprednisolone—systemic lupus erythematosus	3.29e-05	0.00664	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	3.29e-05	0.00664	CbGdCrCtD
Minocycline—IL1B—Immune System—NCF2—systemic lupus erythematosus	3.28e-05	0.00019	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL6—systemic lupus erythematosus	3.28e-05	0.00019	CbGpPWpGaD
Minocycline—IL1B—Immune System—LYN—systemic lupus erythematosus	3.26e-05	0.000189	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—CDKN1A—systemic lupus erythematosus	3.26e-05	0.000189	CbGpPWpGaD
Minocycline—VEGFA—Betamethasone—Dexamethasone—systemic lupus erythematosus	3.24e-05	0.00654	CbGdCrCtD
Minocycline—VEGFA—Dexamethasone—Betamethasone—systemic lupus erythematosus	3.24e-05	0.00654	CbGdCrCtD
Minocycline—IL1B—Immune System—FCGR2A—systemic lupus erythematosus	3.22e-05	0.000187	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL18—systemic lupus erythematosus	3.2e-05	0.000185	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IFNA1—systemic lupus erythematosus	3.19e-05	0.000185	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD40LG—systemic lupus erythematosus	3.18e-05	0.000185	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL2—systemic lupus erythematosus	3.18e-05	0.000185	CbGpPWpGaD
Minocycline—VEGFA—Dexamethasone—Triamcinolone—systemic lupus erythematosus	3.17e-05	0.00639	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Triamcinolone—systemic lupus erythematosus	3.17e-05	0.00639	CbGdCrCtD
Minocycline—IL1B—Immune System—TNFAIP3—systemic lupus erythematosus	3.16e-05	0.000183	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	3.16e-05	0.000183	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD8A—systemic lupus erythematosus	3.15e-05	0.000182	CbGpPWpGaD
Minocycline—IL1B—Immune System—BLK—systemic lupus erythematosus	3.12e-05	0.000181	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	3.12e-05	0.000181	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—RASGRP1—systemic lupus erythematosus	3.11e-05	0.00018	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	3.11e-05	0.00018	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD4—systemic lupus erythematosus	3.1e-05	0.00018	CbGpPWpGaD
Minocycline—CASP1—Immune System—JAK1—systemic lupus erythematosus	3.04e-05	0.000176	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	3.04e-05	0.000176	CbGpPWpGaD
Minocycline—VEGFA—Dexamethasone—Prednisone—systemic lupus erythematosus	3.01e-05	0.00606	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Prednisone—systemic lupus erythematosus	3.01e-05	0.00606	CbGdCrCtD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—systemic lupus erythematosus	3e-05	0.000174	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	2.99e-05	0.000174	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	2.99e-05	0.000173	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.96e-05	0.000171	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.94e-05	0.000171	CbGpPWpGaD
Minocycline—VEGFA—Dexamethasone—Prednisolone—systemic lupus erythematosus	2.94e-05	0.00592	CbGdCrCtD
Minocycline—VEGFA—Betamethasone—Prednisolone—systemic lupus erythematosus	2.94e-05	0.00592	CbGdCrCtD
Minocycline—VEGFA—Developmental Biology—RXRA—systemic lupus erythematosus	2.92e-05	0.000169	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CDKN1B—systemic lupus erythematosus	2.92e-05	0.000169	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.9e-05	0.000168	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TLR9—systemic lupus erythematosus	2.88e-05	0.000167	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—TGFB1—systemic lupus erythematosus	2.88e-05	0.000167	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL6—systemic lupus erythematosus	2.86e-05	0.000166	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2RA—systemic lupus erythematosus	2.84e-05	0.000164	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—JAK1—systemic lupus erythematosus	2.83e-05	0.000164	CbGpPWpGaD
Minocycline—CASP1—Immune System—C3—systemic lupus erythematosus	2.81e-05	0.000163	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTPRC—systemic lupus erythematosus	2.79e-05	0.000162	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.79e-05	0.000162	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL1RN—systemic lupus erythematosus	2.78e-05	0.000161	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.71e-05	0.000157	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CDKN1A—systemic lupus erythematosus	2.69e-05	0.000156	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—IL6—systemic lupus erythematosus	2.69e-05	0.000156	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—IL6—systemic lupus erythematosus	2.69e-05	0.000156	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.68e-05	0.000156	CbGpPWpGaD
Minocycline—CASP1—Immune System—CRP—systemic lupus erythematosus	2.68e-05	0.000155	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.65e-05	0.000153	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.63e-05	0.000153	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NAT2—systemic lupus erythematosus	2.63e-05	0.000152	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—TYK2—systemic lupus erythematosus	2.61e-05	0.000151	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD40—systemic lupus erythematosus	2.6e-05	0.000151	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.58e-05	0.00015	CbGpPWpGaD
Minocycline—CASP1—Immune System—TLR4—systemic lupus erythematosus	2.57e-05	0.000149	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CSK—systemic lupus erythematosus	2.57e-05	0.000149	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DRB1—systemic lupus erythematosus	2.56e-05	0.000149	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EP300—systemic lupus erythematosus	2.56e-05	0.000149	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	2.56e-05	0.000148	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTLA4—systemic lupus erythematosus	2.56e-05	0.000148	CbGpPWpGaD
Minocycline—IL1B—Immune System—HMGB1—systemic lupus erythematosus	2.56e-05	0.000148	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—IL6—systemic lupus erythematosus	2.54e-05	0.000147	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNA1—systemic lupus erythematosus	2.51e-05	0.000146	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—IL6—systemic lupus erythematosus	2.48e-05	0.000144	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	2.46e-05	0.000143	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—JAK1—systemic lupus erythematosus	2.46e-05	0.000142	CbGpPWpGaD
Minocycline—IL1B—Immune System—RASGRP1—systemic lupus erythematosus	2.45e-05	0.000142	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD79A—systemic lupus erythematosus	2.44e-05	0.000142	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—JAK1—systemic lupus erythematosus	2.41e-05	0.00014	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.4e-05	0.000139	CbGpPWpGaD
Minocycline—CYCS—Metabolism—RXRA—systemic lupus erythematosus	2.39e-05	0.000139	CbGpPWpGaD
Minocycline—IL1B—Immune System—PRL—systemic lupus erythematosus	2.37e-05	0.000138	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD80—systemic lupus erythematosus	2.37e-05	0.000137	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NCF2—systemic lupus erythematosus	2.35e-05	0.000136	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LYN—systemic lupus erythematosus	2.33e-05	0.000135	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.29e-05	0.000133	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN1B—systemic lupus erythematosus	2.27e-05	0.000132	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—TYK2—systemic lupus erythematosus	2.27e-05	0.000131	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.26e-05	0.000131	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DQA1—systemic lupus erythematosus	2.25e-05	0.000131	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2RA—systemic lupus erythematosus	2.25e-05	0.000131	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	2.25e-05	0.00013	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—PPARG—systemic lupus erythematosus	2.13e-05	0.000123	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DQB1—systemic lupus erythematosus	2.11e-05	0.000122	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.1e-05	0.000122	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN1A—systemic lupus erythematosus	2.1e-05	0.000121	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.09e-05	0.000121	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—systemic lupus erythematosus	2.03e-05	0.000118	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.02e-05	0.000117	CbGpPWpGaD
Minocycline—CASP1—Immune System—TYK2—systemic lupus erythematosus	2e-05	0.000116	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	2e-05	0.000116	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TLR9—systemic lupus erythematosus	2e-05	0.000116	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL18—systemic lupus erythematosus	2e-05	0.000116	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB1—systemic lupus erythematosus	2e-05	0.000116	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—EP300—systemic lupus erythematosus	1.99e-05	0.000116	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD40LG—systemic lupus erythematosus	1.99e-05	0.000115	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.99e-05	0.000115	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD8A—systemic lupus erythematosus	1.97e-05	0.000114	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—F2—systemic lupus erythematosus	1.96e-05	0.000114	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.93e-05	0.000112	CbGpPWpGaD
Minocycline—IL1B—Immune System—JAK1—systemic lupus erythematosus	1.9e-05	0.00011	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	1.88e-05	0.000109	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.88e-05	0.000109	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.88e-05	0.000109	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNG—systemic lupus erythematosus	1.87e-05	0.000109	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	1.87e-05	0.000108	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TYK2—systemic lupus erythematosus	1.86e-05	0.000108	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—VEGFA—systemic lupus erythematosus	1.85e-05	0.000107	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—PPARG—systemic lupus erythematosus	1.85e-05	0.000107	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—JUNB—systemic lupus erythematosus	1.84e-05	0.000107	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.83e-05	0.000106	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD4—systemic lupus erythematosus	1.81e-05	0.000105	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—systemic lupus erythematosus	1.78e-05	0.000103	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CSK—systemic lupus erythematosus	1.78e-05	0.000103	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2RA—systemic lupus erythematosus	1.77e-05	0.000103	CbGpPWpGaD
Minocycline—IL1B—Immune System—C3—systemic lupus erythematosus	1.76e-05	0.000102	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.75e-05	0.000101	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TLR9—systemic lupus erythematosus	1.73e-05	0.000101	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDKN1B—systemic lupus erythematosus	1.7e-05	9.85e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRL—systemic lupus erythematosus	1.7e-05	9.83e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.69e-05	9.77e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.68e-05	9.74e-05	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—systemic lupus erythematosus	1.68e-05	9.73e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CRP—systemic lupus erythematosus	1.67e-05	9.7e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2—systemic lupus erythematosus	1.66e-05	9.64e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.64e-05	9.53e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NCF2—systemic lupus erythematosus	1.63e-05	9.44e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ALB—systemic lupus erythematosus	1.63e-05	9.44e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LYN—systemic lupus erythematosus	1.62e-05	9.38e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TYK2—systemic lupus erythematosus	1.62e-05	9.38e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR4—systemic lupus erythematosus	1.6e-05	9.3e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DRB1—systemic lupus erythematosus	1.6e-05	9.29e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.59e-05	9.2e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.59e-05	9.2e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDKN1A—systemic lupus erythematosus	1.57e-05	9.09e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS3—systemic lupus erythematosus	1.56e-05	9.03e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CSK—systemic lupus erythematosus	1.55e-05	8.96e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PPARG—systemic lupus erythematosus	1.51e-05	8.75e-05	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.5e-05	8.71e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—EP300—systemic lupus erythematosus	1.49e-05	8.65e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD80—systemic lupus erythematosus	1.48e-05	8.58e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—RXRA—systemic lupus erythematosus	1.47e-05	8.54e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NCF2—systemic lupus erythematosus	1.41e-05	8.2e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LYN—systemic lupus erythematosus	1.4e-05	8.14e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EP300—systemic lupus erythematosus	1.39e-05	8.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.38e-05	7.99e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.37e-05	7.92e-05	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.36e-05	7.91e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ALB—systemic lupus erythematosus	1.36e-05	7.87e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—JAK1—systemic lupus erythematosus	1.36e-05	7.86e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2—systemic lupus erythematosus	1.32e-05	7.65e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VEGFA—systemic lupus erythematosus	1.32e-05	7.64e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—systemic lupus erythematosus	1.31e-05	7.57e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.3e-05	7.55e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NOS3—systemic lupus erythematosus	1.3e-05	7.53e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR5—systemic lupus erythematosus	1.29e-05	7.45e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—JUNB—systemic lupus erythematosus	1.28e-05	7.41e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—systemic lupus erythematosus	1.28e-05	7.4e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—systemic lupus erythematosus	1.27e-05	7.38e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.27e-05	7.34e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—C3—systemic lupus erythematosus	1.26e-05	7.28e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—TYK2—systemic lupus erythematosus	1.25e-05	7.24e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.21e-05	7.04e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—systemic lupus erythematosus	1.21e-05	7.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EP300—systemic lupus erythematosus	1.21e-05	7e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—systemic lupus erythematosus	1.19e-05	6.88e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—EP300—systemic lupus erythematosus	1.18e-05	6.87e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRL—systemic lupus erythematosus	1.18e-05	6.83e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNG—systemic lupus erythematosus	1.17e-05	6.78e-05	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.15e-05	6.65e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.13e-05	6.55e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD4—systemic lupus erythematosus	1.13e-05	6.55e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—systemic lupus erythematosus	1.13e-05	6.55e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—JUNB—systemic lupus erythematosus	1.11e-05	6.43e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—systemic lupus erythematosus	1.11e-05	6.43e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—F2—systemic lupus erythematosus	1.1e-05	6.39e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDKN1B—systemic lupus erythematosus	1.06e-05	6.16e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CD80—systemic lupus erythematosus	1.06e-05	6.13e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.05e-05	6.11e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—systemic lupus erythematosus	1.05e-05	6.09e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2—systemic lupus erythematosus	1.04e-05	6.03e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—systemic lupus erythematosus	1.03e-05	5.97e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRL—systemic lupus erythematosus	1.02e-05	5.93e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—EP300—systemic lupus erythematosus	9.88e-06	5.73e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL2—systemic lupus erythematosus	9.83e-06	5.7e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDKN1A—systemic lupus erythematosus	9.81e-06	5.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—systemic lupus erythematosus	9.8e-06	5.68e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—systemic lupus erythematosus	9.78e-06	5.67e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.57e-06	5.55e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—JAK1—systemic lupus erythematosus	9.42e-06	5.46e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—EP300—systemic lupus erythematosus	9.33e-06	5.41e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARG—systemic lupus erythematosus	9.3e-06	5.39e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—systemic lupus erythematosus	9.11e-06	5.28e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TYK2—systemic lupus erythematosus	8.93e-06	5.17e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR5—systemic lupus erythematosus	8.92e-06	5.17e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2RA—systemic lupus erythematosus	8.79e-06	5.1e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOS3—systemic lupus erythematosus	8.76e-06	5.08e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—C3—systemic lupus erythematosus	8.72e-06	5.06e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALB—systemic lupus erythematosus	8.37e-06	4.85e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—JAK1—systemic lupus erythematosus	8.17e-06	4.74e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NOS3—systemic lupus erythematosus	8e-06	4.64e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—systemic lupus erythematosus	7.91e-06	4.59e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR5—systemic lupus erythematosus	7.75e-06	4.49e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—F2—systemic lupus erythematosus	7.66e-06	4.44e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.63e-06	4.43e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.59e-06	4.4e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—C3—systemic lupus erythematosus	7.57e-06	4.39e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2—systemic lupus erythematosus	7.43e-06	4.31e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CD80—systemic lupus erythematosus	7.34e-06	4.26e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—systemic lupus erythematosus	7.32e-06	4.24e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—systemic lupus erythematosus	7.03e-06	4.07e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7e-06	4.06e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL2—systemic lupus erythematosus	6.82e-06	3.96e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EP300—systemic lupus erythematosus	6.66e-06	3.86e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—F2—systemic lupus erythematosus	6.65e-06	3.85e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CD80—systemic lupus erythematosus	6.37e-06	3.69e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.31e-06	3.66e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TYK2—systemic lupus erythematosus	6.2e-06	3.59e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—systemic lupus erythematosus	6.11e-06	3.54e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—EP300—systemic lupus erythematosus	6.09e-06	3.53e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOS3—systemic lupus erythematosus	6.08e-06	3.53e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL2—systemic lupus erythematosus	5.92e-06	3.43e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.79e-06	3.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TYK2—systemic lupus erythematosus	5.38e-06	3.12e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOS3—systemic lupus erythematosus	5.28e-06	3.06e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.27e-06	3.05e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2—systemic lupus erythematosus	5.16e-06	2.99e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.86e-06	2.82e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EP300—systemic lupus erythematosus	4.63e-06	2.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.57e-06	2.65e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2—systemic lupus erythematosus	4.48e-06	2.59e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.38e-06	2.54e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—systemic lupus erythematosus	4.37e-06	2.53e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—systemic lupus erythematosus	4.24e-06	2.46e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.22e-06	2.45e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.02e-06	2.33e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EP300—systemic lupus erythematosus	4.02e-06	2.33e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.49e-06	2.02e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—systemic lupus erythematosus	3.03e-06	1.76e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—systemic lupus erythematosus	2.63e-06	1.53e-05	CbGpPWpGaD
